Location: Home > Pharma China Web Edition
  • search
  • go
  • Product/R&D News
  • 1/8/2026Alumis Reports Positive Phase 3 Results for Envudeucitinib in Plaque P...
  • 1/7/2026NovaBridge Reports Encouraging Early Data for Givastomig Combo
  • 1/7/2026China Conditionally Approves BeiGene's Sonrotoclax
  • 1/7/2026Zai Lab Secures Second China Approval for Augtyro
  • 1/7/2026Sanofi's Redemplo Wins China Approval for Rare Lipid Disorder FCS
  • 1/7/2026Shanghai ArkBio Secures China Approval for Azstarys in ADHD
  • 1/7/2026GenHouse Pharma Advances MAT2A Inhibitor GH31 With China Trial Approva...
  • 1/7/2026Epigenic Advances FIC Epigenetic HBV Therapy With U.S. IND Clearance
  • 1/6/2026Insilico Medicine Signs $888 Million Oncology Drug Discovery Alliance ...
  • 1/6/2026Merck's First-in-Class PAH Therapy Winrevair Secures China Approval
  • 1/1/2026Akeso's Pempulimab Wins New Approval in China
  • 1/1/2026J&J's Subcutaneous Amivantamab Regimen for EGFR-Mutant Lung Cancer App...
  • 12/30/2025HUTCHMED's Fanregratinib NDA Granted Priority Review in China
  • 12/30/2025Recbio's Files NDA for Shingles Vaccine REC610 China
  • 12/30/2025China Rejects Tianmai Biotech's Oral Insulin Capsule ORMD-0801
  • 12/30/2025AstraZeneca and Daiichi Sankyo Secures Chinese Approval of Enhertu fo...
  • 12/30/2025Innovent's Ipilimumab IBI310 for Neoadjuvant Therapy approved in China
  • 12/30/2025China Approves AstraZeneca and Ionis' Wainua for ATTRv-PN
  • 12/30/2025Simcere Registers Phase 1 MRCT for EGFR/c-Met Bispecific ADC SIM0610 i...
  • 12/30/2025Innovent Submits Clinical Trial Application for Novel Bispecific Dual-...
  • 12/27/2025Telix Advances Regulatory Efforts with Positive China Phase 3 Data
  • 12/27/2025China Approves Novo Nordisk's Sogroya for Pediatric Growth Hormone Def...
  • 12/27/2025Zai Lab's COBENFY Approve in China for Schizophrenia
  • 12/27/2025GRIT's Next-Generation Gene-Edited TIL GT307 Receives FDA IND Approval
  • 12/27/2025NMPA Approves Amgen/UCB's Evenity for Postmenopausal Osteoporosis
  • 12/27/2025China Approves GSK's Nucala for Maintenance Treatment of Eosinophilic ...
  • 12/23/2025CSPC Announces China Approval for Daratumumab Injection
  • 12/23/2025Qilu Launches Phase 1 Trial of FIC CD3/CD20/CD79b Triple Antibody QLS2...
  • 12/23/2025T-MAXIMUM Secures FDA Approval to Advance Off-the-Shelf CAR-T Therapy
  • 12/23/2025China Approves First Global CSF-1R Inhibitor Pimicotinib for Rare Join...
  • Page:1/21 Total number of articles:618: [First][<<] [1] [2] [3] [4] [5] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group